NO177097C - Analogifremgangsmåte for fremstilling av tricykliske leukotrien-antagonister - Google Patents

Analogifremgangsmåte for fremstilling av tricykliske leukotrien-antagonister

Info

Publication number
NO177097C
NO177097C NO910608A NO910608A NO177097C NO 177097 C NO177097 C NO 177097C NO 910608 A NO910608 A NO 910608A NO 910608 A NO910608 A NO 910608A NO 177097 C NO177097 C NO 177097C
Authority
NO
Norway
Prior art keywords
tricyclic
preparation
leukotriene antagonists
analogous process
analogous
Prior art date
Application number
NO910608A
Other languages
English (en)
Norwegian (no)
Other versions
NO910608D0 (no
NO177097B (no
NO910608L (no
Inventor
Darrel Mark Gapinski
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO910608D0 publication Critical patent/NO910608D0/no
Publication of NO910608L publication Critical patent/NO910608L/no
Publication of NO177097B publication Critical patent/NO177097B/no
Publication of NO177097C publication Critical patent/NO177097C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82—Xanthenes
    • C07D311/84—Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82—Xanthenes
    • C07D311/84—Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
    • C07D311/88—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82—Xanthenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82—Xanthenes
    • C07D311/84—Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
    • C07D311/86—Oxygen atoms, e.g. xanthones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrane Compounds (AREA)
NO910608A 1990-02-16 1991-02-15 Analogifremgangsmåte for fremstilling av tricykliske leukotrien-antagonister NO177097C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/481,413 US4996230A (en) 1990-02-16 1990-02-16 Leukotriene antagonists

Publications (4)

Publication Number Publication Date
NO910608D0 NO910608D0 (no) 1991-02-15
NO910608L NO910608L (no) 1991-08-19
NO177097B NO177097B (no) 1995-04-10
NO177097C true NO177097C (no) 1995-07-19

Family

ID=23911845

Family Applications (1)

Application Number Title Priority Date Filing Date
NO910608A NO177097C (no) 1990-02-16 1991-02-15 Analogifremgangsmåte for fremstilling av tricykliske leukotrien-antagonister

Country Status (20)

Country Link
US (1) US4996230A (de)
EP (1) EP0442748B1 (de)
JP (1) JPH04211037A (de)
KR (1) KR910015558A (de)
CN (1) CN1028639C (de)
AR (1) AR247205A1 (de)
AT (1) ATE116980T1 (de)
AU (1) AU631482B2 (de)
CA (1) CA2036523A1 (de)
DE (1) DE69106545T2 (de)
FI (1) FI910728A (de)
HU (1) HU208431B (de)
IE (1) IE910531A1 (de)
IL (1) IL97242A0 (de)
NO (1) NO177097C (de)
NZ (1) NZ237124A (de)
PT (1) PT96760A (de)
RU (1) RU2007401C1 (de)
YU (1) YU27691A (de)
ZA (1) ZA911111B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH30449A (en) * 1991-11-25 1997-05-28 Lilly Co Eli Substituted phenyl phenol leukotriene antagonists
US5352690A (en) * 1992-07-01 1994-10-04 Eli Lilly And Company 1,2,4-trioxygenated benzene derivatives useful as leukotriene antagonists
DE69414348T2 (de) * 1993-06-18 1999-05-12 Otsuka Pharmaceutical Co., Ltd., Tokio/Tokyo Fluorenonderivate, verfahren zu ihrer herstellung sowie wiederherstellungs- und schutzmittel für zentrale und periphere nervendegenerationen
MX9702731A (es) * 1994-10-13 1997-06-28 Pfizer Compuestos de benzopirano y benzo fusionados, composiciones que los contienen y uso de los mismos.
KR100232340B1 (ko) * 1994-10-13 1999-12-01 디. 제이. 우드, 스피겔 알렌 제이 류코트리엔 b4(ltb4) 길항물질로서의 벤조피란 및 벤조-축합된 화합물
US5977077A (en) * 1995-08-28 1999-11-02 Interlab Corporation Xanthone analogs for the treatment of infectious diseases
CA2199104A1 (en) 1996-03-05 1997-09-05 Tsuneaki Hida Xanthene derivatives, their production and use
US6613797B2 (en) 1999-12-02 2003-09-02 Interlab, Inc. Xanthone analogs for treating infectious diseases and complexation of heme and porphyrins
US20060019269A1 (en) * 2002-10-17 2006-01-26 Decode Genetics, Inc. Susceptibility gene for myocardial infarction, stroke, and PAOD, methods of treatment
US20080293750A1 (en) * 2002-10-17 2008-11-27 Anna Helgadottir Susceptibility Gene for Myocardial Infarction, Stroke, Paod and Methods of Treatment
US8158362B2 (en) * 2005-03-30 2012-04-17 Decode Genetics Ehf. Methods of diagnosing susceptibility to myocardial infarction and screening for an LTA4H haplotype
US20100216863A1 (en) * 2004-01-30 2010-08-26 Decode Genetics Ehf. Susceptibility Gene for Myocardial Infarction, Stroke, and PAOD; Methods of Treatment
CN112285355B (zh) * 2020-10-20 2023-01-13 四川大学华西医院 Viridiflorin检测试剂在制备COPD诊断试剂盒中的用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7008627A (de) * 1969-06-25 1970-12-29
US3987088A (en) * 1971-09-08 1976-10-19 Burroughs Wellcome Co. Cyclic carbonyl compounds
FR2278331A1 (fr) * 1974-01-24 1976-02-13 Roussel Uclaf Nouveaux acides carboxyliques et leurs derives, leur application comme medicaments et leur procede de preparation
US4166819A (en) * 1975-09-24 1979-09-04 Abbott Laboratories 4-Aroyl substituted phenoxy methylene-5-tetrazoles
GB1543964A (en) * 1976-04-08 1979-04-11 Ici Ltd Method of antagonising herbicides on soyabean and cotton
FI82832C (fi) * 1982-04-27 1991-04-25 Wellcome Found Foerfarande foer framstaellning av terapeutiskt anvaendbara disubstituerade xanten- och xantonderivat.
SE8400239D0 (sv) * 1984-01-19 1984-01-19 Pharmacia Ab Nya arylettiksyraderivat
US4661607A (en) * 1984-09-21 1987-04-28 Chugai Seiyaku Kabushiki Kaisha Furoxanthone derivatives useful as diuretics
ATE102616T1 (de) * 1986-12-23 1994-03-15 Warner Lambert Co Verbindungen mit antitumoralen und antibakteriellen eigenschaften.
CA1320490C (en) * 1987-01-12 1993-07-20 Darrel M. Gapinski Anti-inflammatory agents
US5242121A (en) * 1991-08-23 1993-09-07 Roto-Mix Enterprises, Ltd. Bale support and cutter

Also Published As

Publication number Publication date
PT96760A (pt) 1991-11-29
DE69106545D1 (de) 1995-02-23
HUT56359A (en) 1991-08-28
NO910608D0 (no) 1991-02-15
JPH04211037A (ja) 1992-08-03
EP0442748B1 (de) 1995-01-11
CN1054066A (zh) 1991-08-28
KR910015558A (ko) 1991-09-30
AU7110391A (en) 1991-08-22
IL97242A0 (en) 1992-05-25
DE69106545T2 (de) 1995-06-01
CA2036523A1 (en) 1991-08-17
FI910728A0 (fi) 1991-02-14
NZ237124A (en) 1992-04-28
CN1028639C (zh) 1995-05-31
RU2007401C1 (ru) 1994-02-15
AU631482B2 (en) 1992-11-26
EP0442748A1 (de) 1991-08-21
HU208431B (en) 1993-10-28
US4996230A (en) 1991-02-26
YU27691A (sh) 1994-04-05
ZA911111B (en) 1992-10-28
FI910728A (fi) 1991-08-17
NO177097B (no) 1995-04-10
NO910608L (no) 1991-08-19
AR247205A1 (es) 1994-11-30
ATE116980T1 (de) 1995-01-15
IE910531A1 (en) 1991-08-28

Similar Documents

Publication Publication Date Title
NO914429L (no) Fremgangsmaate for fremstilling av piperidinylkamfersulfonyloxytocin-antagonister
NO914490D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme tricykliske forbindelser
NO177097C (no) Analogifremgangsmåte for fremstilling av tricykliske leukotrien-antagonister
NO952090L (no) Fremgangsmåte for fremstilling av benzopyranforbindelser
FI902316A0 (fi) Menetelmä valmistaa terapeuttisesti vaikuttavia substituoituja dihydropyrrolitsiiniyhdisteitä
NO176515C (no) Fremgangsmåte for fremstilling av dietere
NO179517C (no) Fremgangsmåte for fremstilling av 8-klorkinolonderivater
EP0434827A4 (en) Quinolinyl-benzopyran derivatives as antagonists of leukotriene d 4?
NO180675C (no) Fremgangsmåte for fremstilling av aromatiske forbindelser
NO931839L (no) Fremgangsm}te for fremstilling av pergolid
NO914985D0 (no) Fremgangsmaate for fremstilling av 15-nitro-tabersonin-derivater
NO178577C (no) Fremgangsmåte til fremstilling av cefalosporin
NO922709L (no) Fremgangsmaate for fremstilling av vanadium-bis-arener
NO174196C (no) Fremgangsmåte for fremstilling av omega-decenol
NO914452D0 (no) Fremgangsmaate for fremstilling av isokinolinderivater
NO950203D0 (no) Fremgangsmåte for fremstilling av propargylazetidion-forbindelser
NO940861D0 (no) Fremgangsmåte for fremstilling av substituerte 2-aminoteraliner
NO174960C (no) Fremgangsmåte ved fremstilling av 2-hydroksy-3-halogen-5-nitropyridiner
NO180301C (no) Fremgangsmåte for fremstilling av azaspiroalkanderivater
NO177305C (no) Fremgangsmåte for fremstilling av 3-substituerte-2-oksindol-derivater
NO963084D0 (no) Fremgangsmåte for fremstilling av pyrrolidinyl-acetamidderivater
NO180631C (no) Fremgangsmåte for fremstilling av bicykliske amidinohydrazoner
FI901604A0 (fi) Uusien tieno-triatsolo-diatsepiinien valmistusmenetelmä
NO175363C (no) Fremgangsmåte for fremstilling av klormetaner
NO914586L (no) Fremgangsmaate for fremstilling av polyeterester